KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Divestments (2019)

Thermo Fisher Scientific filings provide 6 years of Divestments readings, the most recent being $2.0 million for Q3 2019.

  • On a quarterly basis, Divestments changed N/A to $2.0 million in Q3 2019 year-over-year; TTM through Dec 2020 was $2.0 million, a 0.0% change, with the full-year FY2019 number at $1.1 billion, changed N/A from a year prior.
  • Divestments hit $2.0 million in Q3 2019 for Thermo Fisher Scientific, up from $1.8 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $2.0 million in Q3 2019 to a low of $2.0 million in Q3 2019.